Kalvista Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 12.72, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Kalvista Pharmaceuticals Inc in Mar 31 2026 quarter, has decreased to 29 days, compared to 46 days, in the Sep 30 2025 quarter.

If we take a look into Healthcare sector Kalvista Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Kalvista Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KALV Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Sep 30 2025) III. Quarter	(Jul 31 2025) I. Quarter	(Apr 30 2025) IV. Quarter	(Jan 31 2025) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	12.72	7.85	0.74	-	-
KALV's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	29	47	493	-	-
Seq. Receivable Change	-	-	200.05 %	-	-
Seq. Revenue Change	198.44 %	860.17 %	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

KALV Company Profile • Back to KALV Efficiency Comparisons • Compare KALV Receivables Turnover Ratio to its Competitors

Financial Statements
Kalvista Pharmaceuticals Inc 's Accounts Receivable	$ 10 Millions	Visit KALV's Balance sheet
Kalvista Pharmaceuticals Inc 's Sales TTM	$ 56 Millions	Visit KALV's Income Statement
Sources of KALV's Revenues		Visit KALV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KALV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KALV's Growth Rates	KALV's Roa	KALV's Inventory Turnover Ratio	KALV's Dividend Comparisons
KALV's Profitability Ratios	KALV's Roi	KALV's Asset Turnover Ratio	KALV's Dividend Growth
KALV's Valuation Ratios	KALV's Roe	KALV's Financial Strength Ratios	KALV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Marpai Inc	13.59	$ 17.125 Millions	$ 1.261 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Innoviva Inc	13.13	$ 394.185 Millions	$ 30.016 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Lftd Partners Inc	12.55	$ 36.955 Millions	$ 2.945 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Skinhealth Systems Inc	12.27	$ 295.223 Millions	$ 24.052 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Precision Biosciences Inc	11.94	$ 45.073 Millions	$ 3.776 Millions
Teladoc Health Inc	11.94	$ 2,514.453 Millions	$ 210.660 Millions
Option Care Health Inc	11.65	$ 5,666.577 Millions	$ 486.439 Millions
Ensysce Biosciences Inc	11.55	$ 4.708 Millions	$ 0.407 Millions
Crinetics Pharmaceuticals Inc	11.52	$ 18.069 Millions	$ 1.569 Millions
Icu Medical Inc	11.46	$ 2,156.379 Millions	$ 188.157 Millions
Nrc Health	11.42	$ 138.642 Millions	$ 12.138 Millions
Nuvation Bio Inc	11.41	$ 142.121 Millions	$ 12.454 Millions

Date modified: 2026-08-30T14:45:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.